World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
127
Citations
52353
World Ranking
2857
National Ranking
290

Overview

Graham Dunn was affiliated with the University of Manchester in the United Kingdom. Their research spanned multiple disciplines, primarily focusing on medicine and mathematics, with particular emphasis on psychiatry, mental health, and statistical methodologies.

Their work covered several main topics, including:

  • Schizophrenia research and treatment
  • Mental health and patient involvement
  • Mental health and psychiatry
  • Psychosomatic disorders and their treatments
  • Advanced causal inference techniques
  • Statistical methods and Bayesian inference
  • Statistical methods in clinical trials

Their publications appeared in notable venues such as:

  • PsycTESTS Dataset
  • Psychology and Psychotherapy Theory Research and Practice
  • Health Expectations
  • Efficacy and Mechanism Evaluation
  • BMC Medical Research Methodology

Recent papers authored or co-authored by Graham Dunn included:

  • "The service user experience of SlowMo therapy: A co-produced thematic analysis of service users' subjective experience" (2022, Psychology and Psychotherapy Theory Research and Practice)
  • "The impact of Patient and Public Involvement in the SlowMo study: Reflections on peer innovation" (2021, Health Expectations)
  • "Digitally supported CBT to reduce paranoia and improve reasoning for people with schizophrenia-spectrum psychosis: the SlowMo RCT" (2021, Efficacy and Mechanism Evaluation)
  • "The impact of moderator by confounder interactions in the assessment of treatment effect modification: a simulation study" (2022, BMC Medical Research Methodology)
  • "Measuring Reasoning in Paranoia: Development of the Fast and Slow Thinking Questionnaire" (2020, Schizophrenia Bulletin Open)

Frequent collaborators in their research included:

  • Richard Emsley
  • Daniel Freeman
  • Kathryn Greenwood
  • Thomas Ward
  • Amy Hardy

Best Publications

  • Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?

    Kennedy Cruickshank;Lisa Riste;Simon G. Anderson;John S. Wright

  • Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers.

    Glyn Lewis;Anthony J. Pelosi;Ricardo Araya;Graham Dunn

  • Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)

    Peter B. Jones;Thomas R. E. Barnes;Linda Davies;Graham Dunn

  • The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness.

    Michael Phelan;Mike Slade;Graham Thornicroft;Graham Dunn

  • A Brief Mental Health Outcome Scale-Reliability and Validity of the Global Assessment of Functioning (GAF)

    Steven H. Jones;Graham Thornicroft;Michael Coffey;Graham Dunn

  • Psychological investigation of the structure of paranoia in a non-clinical population.

    Daniel Freeman;Philippa A. Garety;Paul E. Bebbington;Benjamin Smith

  • Depressive disorders in Europe: prevalence figures from the ODIN study.

    Jose Luis Ayuso-Mateos;Jose Luis Vázquez-Barquero;Christopher Dowrick;Ville Lehtinen

  • Negative life events, social support and gender difference in depression: a multinational community survey with data from the ODIN study.

    Odd Steffen Dalgard;Christopher Dowrick;Ville Lehtinen;Jose Luis Vazquez-Barquero

  • The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis

    Tom K J Craig;Philippa Garety;Paddy Power;Nikola Rahaman

  • The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity.

    P Bebbington;G Dunn;R Jenkins;G Lewis

  • The Brief Core Schema Scales (BCSS): psychometric properties and associations with paranoia and grandiosity in non-clinical and psychosis samples

    David Fowler;Daniel Freeman;Ben Smith;Elizabeth Kuipers

  • London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase.

    Elizabeth Kuipers;Philippa Garety;David Fowler;Graham Dunn

  • Emotion and psychosis: Links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations

    Ben Smith;David G. Fowler;Daniel Freeman;Paul Bebbington

  • Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes.

    Shôn Lewis;Nicholas Tarrier;Gillian Haddock;Richard Bentall

  • Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia

    Shôn W. Lewis;Thomas R. E. Barnes;Linda Davies;Robin M. Murray

  • Prevalence of psychiatric disorders in young people in the care system.

    Jacinta B McCann;Anthony James;Sylvia Wilson;Graham Dunn

  • Measuring ideas of persecution and social reference: the Green et al. Paranoid Thought Scales (GPTS)

    Cel Green;D Freeman;E Kuipers;PE Bebbington

  • Design and analysis of reliability studies.

    Graham Dunn

  • Mediation and moderation of treatment effects in randomised controlled trials of complex interventions

    Richard Emsley;Graham Dunn;Ian R White

  • Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial

    Anthonty P. Morrison;Paul French;Suzanne L.K. Stewart;Max Birchwood

Frequent Co-Authors

Daniel Freeman
Daniel Freeman University of Oxford
Philippa Garety
Philippa Garety King's College London
David Fowler
David Fowler University of Sussex
Elizabeth Kuipers
Elizabeth Kuipers King's College London
Paul Bebbington
Paul Bebbington University College London
Martin Knapp
Martin Knapp London School of Economics and Political Science
Shôn Lewis
Shôn Lewis University of Manchester
David Challis
David Challis University of Nottingham
Linda Davies
Linda Davies University of Manchester
Richard Emsley
Richard Emsley King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine extends far beyond the traditional MD route. Many students are now turning to alternative pathways such as nursing, healthcare administration, nurse practitioner, and nutrition degrees to enter the healthcare field faster and with more flexibility.

For those seeking practical, patient-facing roles, consider enrolling in an lpn program no entrance exam—an excellent option if you want to start your healthcare career without the pressure of entrance testing. If you’re interested in fast-tracking your leadership path, accelerated healthcare programs offer a way to quickly earn a degree and move into management roles in clinics, hospitals, and health organizations.

Registered nurses wishing to expand their scope of practice can benefit from rn to np programs online, which provide a direct bridge to advanced practitioner credentials. Meanwhile, those interested in preventative health and wellness can pursue online degrees in nutrition to work in clinics, public health, or private practice.

These diverse online healthcare degrees support flexible learning and open the door to rewarding medical careers beyond the traditional physician route.

Best Scientists Citing Graham Dunn

Recently Published Articles